** NeuroOne Medical Technologies NMTC.O shares ~25%
premarket after co prices follow-on
** Co focused on treating neurological disorders sells 3.75
mln shares at $3.20, raises $12 mln for working capital, general
corp purposes urn:newsml:reuters.com:*:nPn50lqKka
** Offering prices at ~22% discount to stock's last close
** NMTC has 12 mln shares outstanding and ~10.4 mln of
public float, per Refinitiv data
** Craig-Hallum sole bookrunner for offering
** Shares down 12.5% YTD and well off their 2021 peak
of$13.50 hit in early Feb
(Lance Tupper is a Reuters market analyst. The views expressed
are his own)
((lance.tupper.tr.com@reuters.net
lance.tupper@tr.com 1-332-219-1430))